There is some preliminary data given to my onc via Dana Farber saying that the 2 year results are showing it is better but not statistically better from either a time or money standpoint. Out of 100 women, not even one more would be saved from a recurrence but out of 1000, 2-3 more would benefit. It is not statistically relevant but the data will not come out until at least 2nd Q 2007 if not later as I believe they are looking for disease free survival.
There is also the question if the improvement comes from covering the patient to the 2 yrs beyond diagnosis mark or if it is the full 2 years.
Kindest regards
Becky
|